Product name | Recombinant Human IL-21 Protein |
---|---|
Catalog No. | RP01312 |
Description | Recombinant Human IL-21 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gln25-Ser155) of human IL-21 (Accession #NP_068575.1) fused with an 6×His tag at the C-terminus. |
Bio-Activity | 1.Measured by its binding ability in a functional ELISA. Immobilized Human IL21R at 2 μg/mL (100 μL/well) can bind Human IL21 with a linear range of 0.078-0.973 μg/mL. 2.Measured by its ability to induce Interferon gamma secretion by human natural killer lymphoma NK-92 cells. The ED50 for this effect is 1.52-6.06 ng/mL, corresponding to a specific activity of 1.65×105~6.58×105 units/mg. |
Purity | > 95% by SDS-PAGE. |
Endotoxin | < 1.0 EU/μg of the protein by LAL method. |
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. |
Species | Human |
Calculated MW | 16.12 kDa |
Synonym | IL21; CVID11; IL-21; Za11 |
---|---|
Expression Host | HEK293 cells |
Tag | C-His |
Swiss-Prot | |
Gene ID |
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|---|
Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
* For research use only. Not for therapeutic or diagnostic purposes.